APPLICATION FOR CONFIDENTIAL TREATMENT Sample Clauses

APPLICATION FOR CONFIDENTIAL TREATMENT. (hereinafter referred to as the Original License Period) unless terminated in accordance with the provisions hereof. Licensee may renew this Agreement for a Second License Period from [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT], provided Licensee has materially fulfilled its obligations hereunder in the Original License Period. Notice of desire to renew shall be given by Licensee no later than [INFORMATION
Sample 1
AutoNDA by SimpleDocs
APPLICATION FOR CONFIDENTIAL TREATMENT for its use of the rights licensed hereunder for the Original License Period, a guaranteed royalty of $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] for the Second License Period, if applicable, and a guaranteed royalty of $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] for the Third License Period, if applicable. The guaranteed royalty shall be paid as follows: For the Original License Period, $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.]. For the Second License Period, if applicable, $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.]. For the Third License Period, if applicable, $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.]. Such guaranteed royalty payments shall be made by Licensee as specified hereinabove whether or not Licensee uses the rights licensed hereunder, and no part of such guaranteed payments shall be repayable to Licensee. Licensee shall also pay to NFLPA an amount equal to [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.]%) of the gross sales of the licensed product(s) covered by this Agreement, less the guaranteed payments specified above for the applicable License Period. Royalties shall be calculated on a quarterly basis and shall be due as of the last day of each May, August, November, and February of this Agreement and must be paid no later than fifteen (15) days following such due dates. Gross sales shall be calculated based on the actual price(s) charged by Licensee to the retailer or consumer directly or to the wholesaler in an arm's length transaction. Licensee shall transact no sale, the effect of which is to reduce the royalty paid by Licensee to NFLPA; provided, however, that Licensee shall be permitted to provide arm's length discounts, allowances, and returns that are normal and customary. Gross sales shall exclude only [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] in any annual period of March 1 to February 28 contained herein, and (b) such exclusion shall be available to Licensee only if Licensee has theretofore fully complied in a timely manner with its obligation hereunder to pay all royalties, including guarantees.
Sample 1
APPLICATION FOR CONFIDENTIAL TREATMENT. Within thirty (30) days from the date hereof, Licensee shall submit to NFLPA a fully paid policy or certificate of insurance naming NFLPA as an insured party, requiring that insurer will not terminate or materially modify such agreement without written notice to NFLPA at least twenty (20) days in advance thereof. NFLPA hereby indemnifies Licensee and undertakes to defend Licensee against, and hold Licensee harmless from, any liabilities, losses, damages, and expenses (including reasonable attorneys' fees and expenses) resulting from claims made or suits brought against Licensee based upon the use by Licensee of the rights licensed in Section 2 strictly as authorized in this Agreement, or any material breach by Licensor of any portion of this Agreement. The indemnification obligations set forth in this Paragraph 8 shall survive the expiration and/or termination of this Agreement.
Sample 1
APPLICATION FOR CONFIDENTIAL TREATMENT. Within thirty (30) days from the date hereof, Licensee shall submit to NFLPA a fully paid policy or certificate of insurance naming NFLPA as an insured party, requiring that insurer will not terminate or materially modify such agreement without written notice to NFLPA at least twenty (20) days in advance thereof.
Sample 1
APPLICATION FOR CONFIDENTIAL TREATMENT. Prior to December 1 of each NFL season, for Players Inc, [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.]. COPYRIGHT AND TRADEMARK NOTICES. Company shall prominently place or cause to be placed Players Inc's "NFLPLAYERS" trademark or trademarks (hereinafter "Players Inc's Trademark") on the licensed products and on packaging, wrapping, advertising (both print and media regardless of medium, e.g., broadcast, Internet, etc.), and any other material, including trade show booths and exhibits, sales catalogues, and other sales/marketing materials in connection with such licensed product(s) that are publicly distributed or relating to such licensed product(s). Players Inc's Trademark appearing on the licensed product(s) and on all materials in connection with the licensed product(s) distributed, or relating to such licensed product(s), shall appear precisely according to the specifications set forth in Appendix B attached hereto, which may be amended from time to time by Players Inc, without variation. Additionally, Company shall imprint or cause to be imprinted the following text on any such licensed product(s) and/or materials therefore: "Officially Licensed Product of PLAYERS INC" and "visit XXXXXXXXXX.XXX" The specific text imprinted shall be subject to Players Inc's sole discretion. For any licensed product, Company shall also prominently place Players Inc's Trademark and a Players Inc "content box" on all NFL football pages of Company's website and on any other page within such website that utilizes the rights licensed hereunder. "Content box" shall be defined as editorial, sweepstakes or other promotional content designed and developed by Players Inc. The placement of Players Inc's Trademark and "content box" shall be in the upper section of the page and immediately visible. The logo and "content box" on each page shall contain the Players Inc URL as follows: XXXXXXXXXX.XXX and shall serve as a hyperlink to the Players Inc website at xxx.xxxxxxxxxx.xxx.
Sample 1
APPLICATION FOR CONFIDENTIAL TREATMENT for the 2008 Stay Cool in School program, $[INFORMATION SUBJECT TO AN APPLICATION CONFIDENTIAL TREATMENT.] minimum spend for the NFL Players Rookie Premiere (not to include player appearance fees) against actual costs such as stadium rental, player transportation, player rooms, player meals, hospitality, jerseys, etc.), $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] to support [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.], $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] on marketing and advertising to promote the football card category, [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] hobby packs for the [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] to be delivered by [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] and $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] on a mutually agreed upon PLAYERS INC activity or marketing initiatives. For the Third License Period, if applicable, $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] minimum spend on player autographs, highlighting and appearance fees, $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] for the 2009 Stay Cool in School program, $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] minimum spend for the NFL Players Rookie Premiere (not to include player appearance fees) against actual costs such as stadium rental, player transportation, player rooms, player meals, hospitality, jerseys, etc., $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] to support [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.], $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] on marketing and advertising to promote the football card category, [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] hobby packs for [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] to be delivered by [INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] and $[INFORMATION SUBJECT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT.] on a mutually agreed upon PLAYERS INC activity or marketing initiatives. Such activities shall not include standard and customary industry trade advertising and sales materials. At the end of each Service Period, if Company has not spent the required amount as marketing payments, a payment equal to the amount of the differenc...
Sample 1
APPLICATION FOR CONFIDENTIAL TREATMENT. Within thirty (30) days from the date hereof, Company shall submit to Players Inc a fully paid policy or certificate of insurance naming Players Inc as an insured party, requiring that insurer will not terminate or materially modify such agreement without written notice to Players Inc at least twenty (20) days in advance thereof. Players Inc hereby indemnifies Company and undertakes to defend Company against, and hold Company harmless from any liabilities, losses, damages, and expenses (including reasonable attorneys' fees and expenses) resulting from claims made or suits brought against Company based upon a breach of any obligation or representation or warranty of Players Inc hereunder. The indemnification obligations set forth in this Paragraph 8 shall survive the expiration and/or termination of this Agreement.
Sample 1
AutoNDA by SimpleDocs

Related to APPLICATION FOR CONFIDENTIAL TREATMENT

  • Confidential Treatment The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.

  • CONFIDENTIAL TREATMENT REQUESTED Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (“[*****]”) to denote where omissions have been made. The confidential material has been filed separately with the Securities and Exchange Commission.

  • CONFIDENTIAL PORTION OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION OMITTED SECTIONS 1.0 THROUGH 3.2.3 CONSIST OF 1.5

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State.

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Treatment of Confidential Information (a) The Parties shall not, and shall cause all other Persons providing Services or having access to information of the other Party that is known to such Party as confidential or proprietary (the “Confidential Information”) not to, disclose to any other Person or use, except for purposes of this Agreement, any Confidential Information of the other Party; provided, however, that the Confidential Information may be used by such Party to the extent that such Confidential Information has been (i) in the public domain through no fault of such Party or any member of such Group or any of their respective Representatives or (ii) later lawfully acquired from other sources by such Party (or any member of such Party’s Group), which sources are not themselves bound by a confidentiality obligation; provided, further, that each Party may disclose Confidential Information of the other Party, to the extent not prohibited by applicable Law: (A) to its Representatives on a need-to-know basis in connection with the performance of such Party’s obligations under this Agreement; (B) in any report, statement, testimony or other submission required to be made to any Governmental Authority having jurisdiction over the disclosing Party; or (C) in order to comply with applicable Law, or in response to any summons, subpoena or other legal process or formal or informal investigative demand issued to the disclosing Party in the course of any litigation, investigation or administrative proceeding. In the event that a Party becomes legally compelled (based on advice of counsel) by deposition, interrogatory, request for documents subpoena, civil investigative demand or similar judicial or administrative process to disclose any Confidential Information of the other Party, such disclosing Party shall provide the other Party with prompt prior written notice of such requirement, and, to the extent reasonably practicable, cooperate with the other Party (at such other Party’s expense) to obtain a protective order or similar remedy to cause such Confidential Information not to be disclosed, including interposing all available objections thereto, such as objections based on settlement privilege. In the event that such protective order or other similar remedy is not obtained, the disclosing Party shall furnish only that portion of the Confidential Information that has been legally compelled, and shall exercise its commercially reasonable efforts (at such other Party’s expense) to obtain assurance that confidential treatment will be accorded such Confidential Information.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • Certain Information The Company agrees to provide Holder at any time and from time to time with such information as Holder may reasonably request for purposes of Holder’s compliance with regulatory, accounting and reporting requirements applicable to Holder.

  • Treatment of Certain Information; Confidentiality Each of the Administrative Agent, the Lenders and the L/C Issuer agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) to its Affiliates and to its and its Affiliates’ respective partners, directors, officers, employees, agents, trustees, advisors and representatives (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party hereto, (e) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions substantially the same as those of this Section, to (i) any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this Agreement or any Eligible Assignee invited to be a Lender pursuant to Section 2.14(c) or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrower and its obligations, (g) with the consent of the Borrower or (h) to the extent such Information (i) becomes publicly available other than as a result of a breach of this Section or (ii) becomes available to the Administrative Agent, any Lender, the L/C Issuer or any of their respective Affiliates on a nonconfidential basis from a source other than the Borrower.

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

Time is Money Join Law Insider Premium to draft better contracts faster.